Navigation Links
Frost & Sullivan to Present the 2009 Excellence in Medical Technologies & Life Sciences Awards

MOUNTAIN VIEW, Calif., March 16 /PRNewswire/ -- Frost & Sullivan is pleased to announce that the firm will be naming the recipients of its 2009 Excellence in Medical Technologies & Life Sciences Awards. The Awards will be announced during a banquet that will take place on Wednesday, March 18, 2009 in San Francisco.


The Medical Technologies & Life Sciences Awards are given to companies that have made a significant contribution to the pharmaceutical, biotech, drug discovery, clinical diagnostics, medical imaging, and medical device industries. Such companies have shown success at meeting the needs of patients and other stakeholders in the healthcare industry, while building world-class companies with strong management teams.

The evening will feature a CEO Roundtable session titled, "CEO Insights: Healthcare and Life Sciences Growth Leadership Panel," in which five senior-level executives will discuss how they have been able to address challenges and still realize growth.

"The Award recipients are pioneers in the industry," explains Frost & Sullivan's Director of Healthcare Research Monali Patel Shastry. "The Awards recognize innovation and an unflinching commitment to serving their end-users and providing value to the industry as a whole."

To choose Award recipients, Frost & Sullivan's healthcare analyst team tracks emerging and existing markets and evaluates the contributions of industry participants. Analysts quantify several market factors for each participant according to predetermined criteria that define innovation in medical technologies and life sciences. The analysts also consider the pace of technology development and deployment, and the potential relevance or significance of the innovation to the overall industry. The Award recipient is ultimately chosen after a thorough evaluation of this research.

The Awards banquet will take place from 5:00 p.m. until 10:00 p.m. on Wednesday, March 18, 2009 at the Hyatt Fisherman's Wharf, located at 555 North Point Street, San Francisco, California 94133. For more information, please contact Jake Wengroff, Global Director, Corporate Communications, at 210.247.3806 or

The Awards banquet will be co-located with 14th Annual Medical Devices 2009: A Frost & Sullivan Executive MindXchange, taking place March 15-17, 2009.

Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit

    Jake Wengroff

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Frost & Sullivan Recognizes Covidien for Its CT Contrast Delivery System With RFID Enabled Intelligence
2. Frost & Sullivan Lauds BioTrove for Providing Research-Enabling Life Sciences and Drug Discovery Technologies
3. Frost & Sullivans Biopharmaceuticals Market Briefing to Address the Use of Embryonic Stem Cells
4. Perceptive Informatics Receives Frost & Sullivan Product Line Strategy Award
5. Pioneer(R) Surgical Technology, Inc. Wins Frost & Sullivans 2009 North American Orthopaedic Tissue Engineering Technology Innovation Award
6. Frost & Sullivan Names Naviscan a Leader in the Future of Molecular Breast Imaging
7. Frost & Sullivan Forecasts Early Rebound: Strong Growth Ahead for Global Economy
8. Frost & Sullivan Sees Microdosing as Compelling Advantage for Big Pharma
9. Frost & Sullivan Recognizes ESBATechs Innovation in Developing Antibody Fragments for Biologic Therapeutics
10. Ganeden Biotech Receives Frost & Sullivan Probiotics Product Innovation Award
11. Frost & Sullivan Commends Honeywell Enraf for Cutting-Edge Products and Post-Sales Support
Post Your Comments:
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... event of the year and one of the premier annual events for pharmaceutical ... ran from 8–11 November 2015, where ISPE hosted the largest number of attendees ...
(Date:11/24/2015)... ... ... The Academy of Model Aeronautics (AMA), led by its Executive Council, has ... Prix, to represent the First–Person View (FPV) racing community. , FPV racing has exploded ... of racing and several new model aviation pilots have joined the community because of ...
(Date:11/24/2015)... 24, 2015  Twist Bioscience, a company focused ... Ph.D., Twist Bioscience chief executive officer, will present ... December 1, 2015 at 3:10 p.m. Eastern Time at The ... --> --> ... Bioscience is on Twitter. Sign up to follow ...
(Date:11/24/2015)... Nov. 24, 2015 Capricor Therapeutics, Inc. ... on the discovery, development and commercialization of first-in-class therapeutics, ... Executive Officer, is scheduled to present at the 2015 ... 10:50 a.m. EST, at The Lotte New York Palace ... . --> ...
Breaking Biology Technology:
(Date:11/10/2015)... About signature verification Signature ... identify and verify the identity of an individual ... secure and accurate method of authentication and is ... because each individual,s signature is highly unique. Signature ... signature of an individual is compared and matched ...
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
(Date:10/29/2015)... , Oct. 29, 2015  Rubicon Genomics, ... for U.S. distribution of its DNA library preparation ... and Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq ... the preparation of NGS libraries for liquid biopsies--the ... diagnostic and prognostic applications in cancer and other ...
Breaking Biology News(10 mins):